会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 112. 发明申请
    • METHOD AND APPARATUS TO MONITOR PULMONARY EDEMA
    • 监测器脉搏波的方法和装置
    • WO2004101062A2
    • 2004-11-25
    • PCT/US2004/013152
    • 2004-04-28
    • MEDTRONIC, INC.BURNES, John, E.
    • BURNES, John, E.
    • A61N
    • A61B5/0472A61M5/14276A61N1/3627A61N1/3702
    • In general, the invention is directed to monitoring fluid retention that may accompany congestive heart failure and pulmonary edema. A medical device, such as an implanted pacemaker or an external defibrillator, senses electrical signals associated with the periodic depolarization and re-polarization of a heart. The device processes the electrical signals to obtain one or more "cardiac parameters," which reflect pulmonary edema. By monitoring the cardiac parameters, the device monitors pulmonary edema. Cardiac parameters comprise the amplitude of the QRS complex, the integral of the QRS complex, or the integral of the QRST segment and the like. When the device detects fluid buildup, the device may respond by taking remedial action and/or generating an alert.
    • 通常,本发明涉及监测可伴随充血性心力衰竭和肺水肿的液体保留。 诸如植入式心脏起搏器或外部除颤器之类的医疗装置感测到与心脏的周期性去极化和再极化相关联的电信号。 该装置处理电信号以获得反映肺水肿的一个或多个“心脏参数”。 通过监测心脏参数,该装置监测肺水肿。 心脏参数包括QRS波段的振幅,QRS波段的积分或QRST段的积分等。 当设备检测到液体积聚时,设备可以通过采取补救措施和/或产生警报来做出响应。
    • 113. 发明申请
    • CARDIAC PACING FOR OPTIMAL INTRA-LEFT VENTRICULAR RESYNCHRONIZATION
    • CARDIAC PACING用于最佳的左心室再生
    • WO2004096345A2
    • 2004-11-11
    • PCT/US2004/011649
    • 2004-04-14
    • MEDTRONIC, INC.PRINZEN, Frits, W.VERBEEK, Marcel A. E.
    • PRINZEN, Frits, W.VERBEEK, Marcel A. E.
    • A61N1/00
    • A61N1/368
    • Cardiac pacing to treat ventricle dysynchrony for improved cardiac function is performed as follows. Early paced inter-ventricular asynchrony is determined during ventricular pacing. Baseline inter-ventricular asynchrony is determined without pacing. Average inter-ventricular asynchrony is calculated by averaging the early paced inter-ventricular asynchrony and the baseline inter-ventricular asynchrony. Atrio-ventricular delay and ventricular-ventricular delay are adjusted during ventricular pacing to yield the average nter-ventricular asynchrony for optimal intra-left ventricular resynchronization and maximal cardiac function. The elements above can be configured in software contained in an implantable medical device or embodied as a computer software product that includes a medium readable by a processor.
    • 心脏起搏治疗心室异常以改善心脏功能如下进行。 在心室起搏期间确定早期起搏心室间不同步。 确定基线心室间不同步,无起搏。 平均心室间异常是通过对早期起搏心室间不同步和基线心室间不同步进行平均来计算的。 在心室起搏期间调节心室延迟和心室 - 心室延迟,以产生最佳左心室再同步和最大心脏功能的平均心室不同步。 上述元件可以用包含在可植入医疗设备中的软件来配置,或者被实现为包括可由处理器读取的介质的计算机软件产品。
    • 114. 发明申请
    • VENTRICULAR RATE STABILIZATION WITH CARDIAC RESYNCHRONIZATION
    • 心脏再生能力的稳定性稳定性
    • WO2004096341A2
    • 2004-11-11
    • PCT/US2004/012263
    • 2004-04-20
    • MEDTRONIC, INC.VAN OORT, GeeskeVAN HOVE, Jos, W.
    • VAN OORT, GeeskeVAN HOVE, Jos, W.
    • A61N
    • A61N1/368A61N1/3684
    • An implantable medical device (IMD) selectively switches to a more hemodynamically beneficial pacing mode upon detection of ventricular dysynchrony and/or reduced hemodynamic function during delivery of pacing pulses according to a ventricular rate stabilization algorithm. For example, in some embodiments of the invention, an IMD switches from right ventricular pacing according to a ventricular rate stabilization algorithm, to biventricular pacing according to the algorithm. The biventricular pacing can be provided according to a cardiac resynchronization therapy mode, and can involve use of an intraventricular delay between delivery of pacing pulses to the respective ventricles to improve hemodynamic functioning of a heart. The IMD monitors an electrogram signal to detect ventricular dysynchrony and/or decreased hemodynamic performance of the ventricles. The IMD can detect ventricular dysynchrony based on elongated QRS complex widths. The IMD can detect decreased hemodynamic performance based on shortened Q-T intervals and/or decreased ventricular evoked response amplitudes.
    • 根据心室速率稳定算法,可以在检测到心室异常和/或在递送起搏脉冲期间降低的血液动力学功能时,可植入医疗装置(IMD)选择性地切换到更有效的起搏方式。 例如,在本发明的一些实施例中,IMD根据心室速率稳定算法从右心室起搏切换到根据该算法的双心室起搏。 可以根据心脏再同步治疗模式提供双心室起搏,并且可以涉及在将起搏脉冲递送到各个心室之间使用室内延迟以改善心脏的血液动力学功能。 IMD监测电描记图信号以检测心室异常和/或降低心室的血液动力学性能。 IMD可以根据延长的QRS复杂宽度来检测心室异常。 IMD可以基于缩短的Q-T间期和/或降低的心室诱发反应幅度来检测血液动力学性能降低。
    • 115. 发明申请
    • METHOD AND APPARATUS FOR IMPEDANCE SIGNAL LOCALIZATIONS FROM IMPLANTED DEVICES
    • 用于来自植入装置的阻抗信号定位的方法和装置
    • WO2004096041A2
    • 2004-11-11
    • PCT/US2004/011470
    • 2004-04-14
    • MEDTRONIC, INC.WANG, Li
    • WANG, Li
    • A61B5/053
    • A61N1/36521A61B5/053A61B5/0809A61B5/7285
    • Method and apparatus for monitoring a plurality of physiological factors contributing to physiological conditions of a heart, that determines a first impedance, corresponding to the plurality of physiological factors, across a plurality of vectors, and a second impedance, corresponding to the plurality of physiological factors, across the plurality of vectors subsequent to determining the first impedance. A relative change in impedance corresponding to the plurality of vectors is determined in response to the first impedance and the second impedance, first minimally contributing physiological factors of the plurality of physiological factors associated with a first physiological factor of the plurality of physiological factors are determined, and relative change in tissue resistivity corresponding to the first physiological factor in response to physiological factors of the plurality of physiological factors other than the first minimal contributing physiological factors and the relative change in impedance are determined.
    • 用于监测对心脏的生理状况有贡​​献的多个生理因素的方法和装置,所述多个生理因素确定对应于多个生理因素的第一阻抗,跨多个矢量,并且第二阻抗 ,其对应于所述多个生理因素,在确定所述第一阻抗之后跨越所述多个矢量。 响应于第一阻抗和第二阻抗确定与多个矢量相对应的阻抗的相对变化,首先确定与多个生理因素中的第一生理因素相关联的多个生理因素中的最小生理因素, 并且响应于除第一最小有助于生理因素之外的多个生理因素的生理因素以及阻抗的相对变化来确定对应于第一生理因素的组织电阻率的相对变化。
    • 118. 发明申请
    • SLOW RISE DEFIBRILLATION WAVEFORMS FOR A PULSE MODULATED CIRCUIT
    • 用于脉冲调制电路的缓慢上升的波形波形
    • WO2004050183A1
    • 2004-06-17
    • PCT/US2003/038312
    • 2003-12-03
    • MEDTRONIC, INC.
    • BELK, Paul, A.DEGROOT, Paul, J.
    • A61N1/39
    • A61N1/3906
    • The present invention provides structures and methods for delivering a complex slow-rise defibrillation waveform wherein in lieu of the simple truncation of prior art defibrillation waveforms, when a predetermined amplitude is reached for an ascending waveform (e.g., a ramp waveform), the waveform transitions to an exponential decay portion for a period of time and at the expiration of the period of time, a truncation occurs. In the event that a first complex bi-phasic ramp wave form is implemented, a second opposite polarity waveform may be delivered. Said second waveform is preferably of similar shape to the first waveform, but of a less magnitude amplitude, although the second waveform may comprise a traditional waveform. The implementation and feasibility of the waveforms according to the present invention in an ICD or an AED is relatively simple while providing significant advantages not previously known or used in the prior art.
    • 本发明提供了用于递送复合慢速除颤波形的结构和方法,其中,当对于上升波形(例如,斜坡波形)达到预定幅度时,代替现有技术除颤波形的简单截断,波形转换 到指数衰减部分一段时间,并且在该时间段到期时,发生截断。 在实现第一复杂的双相斜波波形的情况下,可以传送第二相反极性波形。 所述第二波形优选地具有与第一波形相似的形状,但幅度较小的幅度,尽管第二波形可以包括传统波形。 根据本发明的波形在ICD或AED中的实现和可行性相对简单,同时提供了现有技术中未曾知道或使用的显着优点。
    • 119. 发明申请
    • ISCHEMIA DETECTION
    • ISCHEMIA检测
    • WO2004047917A1
    • 2004-06-10
    • PCT/US2003/035881
    • 2003-11-12
    • MEDTRONIC, INC.
    • SHELDON, Todd, J.NELSON, Shannon, D.STYLOS, LeeSTADLER, Robert, W.
    • A61N1/365
    • A61N1/368A61N1/3627A61N1/36585
    • Techniques for detection and treatment of myocardial ischemia are described that monitor both the electrical and dynamic mechanical activity of the heart to detect and verify the occurrence of myocardial ischemia in a more reliable manner. The occurrence of myocardial ischemia can be detected by monitoring changes in an electrical signal such as an ECG or EGM, and changes in dynamic mechanical activity of the heart that are sensed by an accelerometer sensor. The heart acceleration signal can be obtained from an single- or multiple-axis accelerometer and/or a pressure sensor deployed within or near the heart. The techniques correlate contractility changes detected by an accelerometer or pressure sensor with changes in the ST electrogram segment detected by the electrodes to increase the reliability of ischemia detection.
    • 描述了用于检测和治疗心肌缺血的技术,其监测心脏的电和动态机械活性以更可靠的方式检测和验证心肌缺血的发生。 可以通过监测诸如ECG或EGM的电信号的变化以及由加速度计传感器感测到的心脏的动态机械活动的变化来检测心肌缺血的发生。 心脏加速度信号可以从部署在心脏内部或附近的单轴或多轴加速度计和/或压力传感器获得。 该技术将由加速度计或压力传感器检测到的收缩性变化与由电极检测到的ST电描绘部分的变化相关联,以增加缺血检测的可靠性。
    • 120. 发明申请
    • APPARATUS AND METHOD FOR OPTIMIZING CAPACITOR CHARGE IN A MEDICAL DEVICE
    • 在医疗设备中优化电容器充电的装置和方法
    • WO2004030749A1
    • 2004-04-15
    • PCT/US2003/030568
    • 2003-09-26
    • MEDTRONIC, INC.
    • NORTON, John, D.RORVICK, Anthony, W.
    • A61N1/00
    • A61N1/3975A61N1/3981
    • A medical device for electrical termination of an arrhythmic condition of a patient's heart in embodiments of the invention may include one or more of the following features: (a) at least one battery; (b) means for detection of an arrhythmic condition of a patient's heart; (c) at least one high voltage capacitor; (d) converter means for providing charging current from said battery to said capacitor; (e) means for maintenance of a charge on said capacitor between arrhythmia therapies; (f) controller means responsive to detection of an arrhythmic condition of said patient's heart and for providing a discharge control signal; and (g) discharge circuit means for delivering voltage stored on said capacitor to said patient's heart in response to said discharge control signal.
    • 在本发明的实施例中用于电终止患者心脏的心律失常状态的医疗装置可以包括以下特征中的一个或多个:(a)至少一个电池; (b)检测患者心脏的心律不齐症的手段; (c)至少一个高电压电容器; (d)用于从所述电池向所述电容器提供充电电流的转换器装置; (e)用于在心律失常治疗之间维持所述电容器上的电荷的装置; (f)响应于所述患者心脏的心律失常状态的检测并用于提供放电控制信号的控制器装置; 以及(g)放电电路装置,用于响应于所述放电控制信号将存储在所述电容器上的电压传送到所述患者的心脏。